← Back to directory
QV
Qiming Venture Partners
Shanghai, ChinaWebsite ↗
Qiming Venture Partners is a leading China-based venture capital firm founded in 2006, specializing in early and growth-stage investments across the technology and healthcare sectors. The firm strives to be the preferred investor for top entrepreneurs, offering strategic capital, resources, and operational support to foster growth and create lasting societal value.
Last raised
Mar 2023
3y 7mo ago
Latest fund size
$550M
Qiming Venture Partners USA's third fund
AUM
$9.5B
estimated
Funds raised
Capital this firm has raised, newest first
Qiming Venture Partners USA's third fund
Mar 2023
$550M
USD Fund VIII and RMB Fund VII
Jul 2022
$3.2B
RMB Fund VI
Jan 2021
$441.1M
Qiming Venture Partners Fund VII
Nov 2020 · USD Fund VII
$1.2B
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| LTZ Therapeutics | — | — | May 2026 | source ↗ |
| Aureka Biotechnologies | — | — | Apr 2026 | source ↗ |
| OriCell Therapeutics | — | — | Apr 2026 | source ↗ |
| ShengShu Technology | — | — | Apr 2026 | source ↗ |
| Inspire-Robot | — | — | Apr 2026 | source ↗ |
| Ace Robotics | — | — | Apr 2026 | source ↗ |
| Nature Select | — | — | Apr 2026 | source ↗ |
| Soda Health | Series B | $50M | Dec 2024 | source ↗ |
Sources
Where this data came from